Inhibition of RIP and c-FLIP enhances TRAIL-induced apoptosis in pancreatic cancer cells
- 1 November 2007
- journal article
- Published by Elsevier BV in Cellular Signalling
- Vol. 19 (11), 2237-2246
- https://doi.org/10.1016/j.cellsig.2007.06.001
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- The Current Status of Combined Radiotherapy and Chemotherapy for Locally Advanced or Resected Pancreas CancerJournal of the National Comprehensive Cancer Network, 2005
- The anti-tumor effect of Apo2L/TRAIL on patient pancreatic adenocarcinomas grown as xenografts in SCID miceJournal of Translational Medicine, 2005
- Predominant Bcl-XL Knockdown Disables Antiapoptotic Mechanisms: Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Based Triple Chemotherapy Overcomes Chemoresistance in Pancreatic Cancer Cells In vitroCancer Research, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoterCancer Gene Therapy, 2004
- Suppressing Orthotopic Pancreatic Tumor Growth with a Fiber-Modified Adenovector Expressing the TRAIL Gene from the Human Telomerase Reverse Transcriptase PromoterClinical Cancer Research, 2004
- Nature's TRAIL—On a Path to Cancer ImmunotherapyImmunity, 2003
- Pancreatic Adenocarcinoma Cell Lines Show Variable Susceptibility to TRAIL-Mediated Cell DeathPancreas, 2001
- Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancerCancer Letters, 2001
- Death Receptors: Signaling and ModulationScience, 1998